Anti-GLUT1 monoclonal antibody decreases glucose uptake in the MDA-MB-231 TNBC cell line, and decreases cancer cell proliferation and promotes apoptosis in MCF-1 and T47D breast cancer cell lines (Rastogi et al., 2007). Here, SLC2A1 is linked to breast carcinoma.